Biogen Shares Tick Lower On Volume As Traders Circulate Word Of Negative Comments From RBC Capital Suggesting Firm's Checks Have Detected Co.'s Study Of BG00011 Has Been Discontinued Due To Toxicity
Benzinga Newsdesk